CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net loss for the period	$ (14,266,035)	$ (954,156)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation and amortization	56,737	5,851
Stock-based compensation	224,069	90,000
Option-based consulting fees - lending commitment	11,719,170	0
Gain on forgiveness of trade payables	0	(24,029)
Loss on sale of vehicle	5,573	0
Net change in assets and liabilities:
Decrease in contract receivables	7,638	186,917
(Increase) decrease in prepaid expenses	32,678	(98,194)
(Increase) in deferred project costs	(1,079,017)	0
(Increase) in other current assets	(24,638)	0
(Increase) in other assets	(480)	(8,440)
Increase in accounts payable - trade	258,089	77,471
(Decrease) in advances from shareholders	0	(38,550)
Increase in accrued liabilities	1,015,588	131,160
Net cash (used in) operating activities	(2,050,628)	(631,970)
Cash flows from investing activities:
Purchases of property and equipment	(5,573)	0
Cash distributions prior to merger	0	(9,998)
Disposition of property and equipment	521	(14,116)
Net cash (used in) investing activities	(5,052)	(24,114)
Cash flows from financing activities:
Net proceeds from line of credit from related party	500,000	5,000
Cash received from Nyserda funding	480,000	0
Borrowings under bridge loans from affiliates	239,400	0
Cash proceeds from merger transaction	0	1,100,000
Repayment of debt on installment notes	(7,316)	(7,978)
Net cash provided by financing activities	1,212,084	1,097,022
Net increase (decrease) in cash	(843,596)	440,938
Cash - beginning of period	896,057	18,241
Cash - end of period	52,461	459,179
Supplemental disclosure of cash flow information:
Cash payments for interest	5,101	11,105
Non-Cash Investing and Financing Transactions:
Deferred project costs included in accounts payable	$ 360,619	$ 0